Literature DB >> 16438049

Binding of G-quadruplex-interactive agents to distinct G-quadruplexes induces different biological effects in MiaPaCa cells.

Weijun Liu1, Daekyu Sun, Laurence H Hurley.   

Abstract

Our previous studies have demonstrated the preference of telomestatin for intramolecular, rather than the intermolecular, G-quadruplex structures, while TiMPyP4 has selectivity for intermolecular over intramolecular G-quadruplex structures. However, it was not clear whether the difference in the selectivity between two different G-quadruplex-interactive agents could determine the corresponding biological effects in cultured human tumor cells. Here we evaluated the biological effects of both TMPyP4 and telomestatin in the human pancreatic carcinoma cell line (MiaPaCa) using subtoxic and cytotoxic concentrations. The cytotoxicity of these agents against MiaPaCa cells is quite different, and the IC50 of telomestatin (0.5 microM) is about 100 times less than that of TMPyP4 (50 microM). At IC50 concentrations, TMPyP4 induced anaphase bridge formation in MiaPaCa cells, while telomestatin failed to induce anaphase bridge formation. At subtoxic concentrations, TMPyP4 induced MiaPaCa cell growth arrest, senescence, apoptosis, and telomere length shortening within 5 weeks, while similar biological effects were evident after 12 weeks following treatment with telomestatin. Our data suggest that binding of G-quadruplex-interactive agents to distinct G-quadruplexes could induce different biological effects in human cancer cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16438049     DOI: 10.1080/15257770500267238

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  12 in total

1.  Macrocyclic pyridyl polyoxazoles: selective RNA and DNA G-quadruplex ligands as antitumor agents.

Authors:  Suzanne G Rzuczek; Daniel S Pilch; Angela Liu; Leroy Liu; Edmond J LaVoie; Joseph E Rice
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

2.  "One ring to bind them all"-part I: the efficiency of the macrocyclic scaffold for g-quadruplex DNA recognition.

Authors:  David Monchaud; Anton Granzhan; Nicolas Saettel; Aurore Guédin; Jean-Louis Mergny; Marie-Paule Teulade-Fichou
Journal:  J Nucleic Acids       Date:  2010-05-24

3.  Bisquinolinium compounds induce quadruplex-specific transcriptome changes in HeLa S3 cell lines.

Authors:  Rashi Halder; Jean-Francois Riou; Marie-Paule Teulade-Fichou; Tancred Frickey; Jörg S Hartig
Journal:  BMC Res Notes       Date:  2012-03-13

Review 4.  Quadruplex DNA: sequence, topology and structure.

Authors:  Sarah Burge; Gary N Parkinson; Pascale Hazel; Alan K Todd; Stephen Neidle
Journal:  Nucleic Acids Res       Date:  2006-09-29       Impact factor: 16.971

5.  TMPyP4, a Stabilizer of Nucleic Acid Secondary Structure, Is a Novel Acetylcholinesterase Inhibitor.

Authors:  Nana Fujiwara; Michael Mazzola; Elizabeth Cai; Meng Wang; John W Cave
Journal:  PLoS One       Date:  2015-09-24       Impact factor: 3.240

6.  Antitumor activity of G-quadruplex-interactive agent TMPyP4 with photodynamic therapy in ovarian carcinoma cells.

Authors:  Hongli Liu; Changshuai Lv; Baijuan Ding; Jie Wang; Shan Li; Youzhong Zhang
Journal:  Oncol Lett       Date:  2014-05-08       Impact factor: 2.967

7.  TERRA G-quadruplex RNA interaction with TRF2 GAR domain is required for telomere integrity.

Authors:  Yang Mei; Zhong Deng; Olga Vladimirova; Nitish Gulve; F Brad Johnson; William C Drosopoulos; Carl L Schildkraut; Paul M Lieberman
Journal:  Sci Rep       Date:  2021-02-10       Impact factor: 4.996

Review 8.  G-quadruplexes: a promising target for cancer therapy.

Authors:  Annkristin Heine; Katrin Paeschke; Nils Kosiol; Stefan Juranek; Peter Brossart
Journal:  Mol Cancer       Date:  2021-02-25       Impact factor: 27.401

Review 9.  Specific binding of anionic porphyrin and phthalocyanine to the G-quadruplex with a variety of in vitro and in vivo applications.

Authors:  Hidenobu Yaku; Takashi Murashima; Daisuke Miyoshi; Naoki Sugimoto
Journal:  Molecules       Date:  2012-09-05       Impact factor: 4.411

Review 10.  Chromatin as a target for the DNA-binding anticancer drugs.

Authors:  Parijat Majumder; Suman K Pradhan; Pukhrambam Grihanjali Devi; Sudipta Pal; Dipak Dasgupta
Journal:  Subcell Biochem       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.